
Resilience is a global, clinical-stage medtech company specializing in oncology, gastroenterology, and psychiatry. We develop digital solutions that transform patient care and generate robust clinical data to improve treatments. As a true sponsor, we are conducting multiple prospective randomized clinical trials to obtain regulatory approvals in Europe and the United States.
In a nutshell:
The Vice President, Clinical Development will own and lead all sponsor-led clinical development activities at Resilience across oncology, gastroenterology, and psychiatry.
This role is accountable for the strategic direction, design, and execution of Resilience-sponsored clinical trials and real-world evidence programs, ensuring consistency, scientific rigor, operational excellence, and regulatory readiness across all business units.
Reporting to the Chief Medical Officer, the VP Clinical Development will build and lead a centralized Clinical Development organization, composed of Clinical Leads and Clinical Scientists, and will serve as the single point of accountability for clinical development execution at the company level.
Nice to have: Experience in digital therapeutics or biotechs that have obtained CE/FDA approvals.
GDPR : Your personal data will be processed for the purposes of recruitment related activities, which include setting up and conducting interviews and tests for applicants, evaluating and assessing the results thereto, and as is otherwise needed in the recruitment and hiring processes. They will be available only for people involved in the process and erased after 2 years of inactivity.
Under GDPR and as Resilience attach great importance to privacy, please note that you have the right to request access to your personal data, to request that your personal data be rectified or erased. The Data Protection Officer can be contacted at privacy@resilience.care
For more information, please check our privacy policy.

Resilience Care, a major player in remote patient monitoring and a partner in clinical research, is a French company founded in 2021 with one mission: to provide better care. The company offers remote monitoring solutions in oncology, gastroenterology, and psychiatry, which are routinely used by 23,000 patients in more than 150 healthcare facilities and in more than 20 academic and industrial clinical studies. Resilience Care harnesses data for healthcare and therapeutic innovation with the ambition of enabling every patient with a chronic disease to benefit from personalized medicine.
The Resilience Oncology remote patient monitoring solution is dedicated to cancer patients (all cancers, all stages, and all treatments). It combines two tools:
A monitoring platform for healthcare professionals (CE Class IIa certified medical device) that enables early detection of side effects and improves patient care.
A mobile app for patients that allows them to report their symptoms and benefit from personalized resources throughout their care journey.